Mechanistic description
Trazodone’s 5-HT2A antagonism reduces matrix metalloproteinase-9 (MMP-9) expression in cerebral endothelial cells, preserving tight junction proteins (claudin-5, ZO-1) and maintaining BBB integrity. This prevents peripheral inflammatory cell infiltration and reduces parenchymal A-beta accumulation secondary to impaired drainage. However, BBB dysfunction in human AD may be a consequence rather than a cause of neurodegeneration, and the relative contribution of this mechanism to overall disease modification is likely secondary.
Evidence for (9)
MMP-9 degrades tight junctions and exacerbates neuroinflammation in AD
5-HT2A antagonism reduces MMP-9 activity in stroke models
BBB dysfunction correlates with cognitive decline in human studies
Evidence against (3)
BBB dysfunction may be a downstream consequence rather than primary disease driver
Mechanism is likely secondary to other more direct neuroprotective effects of trazodone
Human genetic data do not support tight junction genes as major AD risk factors
Evidence matrix
Supporting
- MMP-9 degrades tight junctions and exacerbates neuroinflammation in AD PMID:30392788
- 5-HT2A antagonism reduces MMP-9 activity in stroke models PMID:26254491
- BBB dysfunction correlates with cognitive decline in human studies PMID:31196952
Contradicting
- BBB dysfunction may be a downstream consequence rather than primary disease driver PMID:31196952
- Mechanism is likely secondary to other more direct neuroprotective effects of trazodone PMID:30392788
- Human genetic data do not support tight junction genes as major AD risk factors PMID:30617331
Bayesian persona consensus
scidex.consensus.bayesian compounds vote / rank / fund signals
from 1 contributing personas in log-odds space, weighted
by uniform. Prior 50%.
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). HTR2A-Mediated MMP-9 Suppression Preserves BBB Integrity at Low Doses. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-SDA-2026-04-26-gap-pubmed-20260411-081101-dfe3eacb-06-htr2a-mediated-mmp-9-suppression-preserves-bbb-i-2a9039ebb3
@misc{scidex_hypothesis_hsda2026,
title = {HTR2A-Mediated MMP-9 Suppression Preserves BBB Integrity at Low Doses},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-SDA-2026-04-26-gap-pubmed-20260411-081101-dfe3eacb-06-htr2a-mediated-mmp-9-suppression-preserves-bbb-i-2a9039ebb3},
note = {SciDEX artifact hypothesis:h-SDA-2026-04-26-gap-pubmed-20260411-081101-dfe3eacb-06-htr2a-mediated-mmp-9-suppression-preserves-bbb-i-2a9039ebb3}
}